Noticias y Actividades de Deciphera Pharmaceuticals
Presencia
ONO Pharmaceutical es una de las ...
ONO Pharmaceutical es una empresa que cotiza bajo el símbolo de cotización 4528 (JP).
ONO Pharmaceutical tiene presencia directa en 2 países.
Fusión, adquisición y financiación con participación de ONO Pharmaceutical.
Ejecutivos
Ver el organigrama con sus 13 ejecutivos principales
Biografías más buscadas en Deciphera Pharmaceuticals
- Ryota Udagawa, Chief Executive Officer and President
- Toichi Takino, Director
- Masayuki Tanigawa, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Deciphera Pharmaceuticals.
Farmacia
ONO Pharmaceutical tiene 1.824 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Roche (Suiza).
Popular M&A news in Farmacia
- Cyclo Therapeutics ha Rafael Holdings adquirido (publicado el 28 de abril de 2025).
- Chimerix and Chimerix have merged (publicado el 22 de abril de 2025)..
- Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- View more press releases Close
Redes sociales sobre Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Deciphera Pharmaceuticals en LinkedIn, Twitter y YouTube
